Selective serotonin reuptake inhibitors in women with borderline personality disorder

2003 ◽  
Vol 5 (3) ◽  
pp. 176-177
Author(s):  
Joachim F. Hallmayer
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Borderline Personality ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin

scholarly journals Drug treatment for personality disorders

2004 ◽  
Vol 10 (5) ◽  
pp. 389-398 ◽  
Author(s):  
Peter Tyrer ◽  
Anthony W. Bateman
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Monoamine Oxidase ◽  
Personality Disorders ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Antipsychotic Drugs ◽  
Borderline Personality ◽  
Trial Data ◽  
Careful Management

There is some evidence that antidepressants, particularly the selective serotonin reuptake inhibitors and the monoamine oxidase inhibitors, have some benefits in the management of borderline personality disorder, and lesser evidence (partly because of limited trial data) for the benefits of antipsychotic drugs and mood stabilisers. There is not sufficient distinction between the different personality disorders to recommend that any one disorder should be treated by any one drug, and successful treatment is dependent on careful management, sensitive to the patient's expectations.

Sign in / Sign up

Export Citation Format

Share Document